- Home
- PPL vs BNTX Comparison
PPL vs BNTX Comparison
Compare PPL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPL
- BNTX
- Stock Information
- Founded
- PPL 1920
- BNTX 2008
- Country
- PPL United States
- BNTX Germany
- Employees
- PPL N/A
- BNTX N/A
- Industry
- PPL Electric Utilities: Central
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PPL Utilities
- BNTX Health Care
- Exchange
- PPL Nasdaq
- BNTX Nasdaq
- Market Cap
- PPL 23.8B
- BNTX 23.9B
- IPO Year
- PPL N/A
- BNTX 2019
- Fundamental
- Price
- PPL $32.50
- BNTX $115.21
- Analyst Decision
- PPL Buy
- BNTX Strong Buy
- Analyst Count
- PPL 12
- BNTX 15
- Target Price
- PPL $35.58
- BNTX $143.50
- AVG Volume (30 Days)
- PPL 4.0M
- BNTX 659.5K
- Earning Date
- PPL 02-14-2025
- BNTX 11-04-2024
- Dividend Yield
- PPL 3.17%
- BNTX N/A
- EPS Growth
- PPL 1.20
- BNTX N/A
- EPS
- PPL 1.11
- BNTX N/A
- Revenue
- PPL $8,282,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- PPL $0.66
- BNTX N/A
- Revenue Next Year
- PPL $0.80
- BNTX N/A
- P/E Ratio
- PPL $29.36
- BNTX N/A
- Revenue Growth
- PPL N/A
- BNTX N/A
- 52 Week Low
- PPL $25.35
- BNTX $76.53
- 52 Week High
- PPL $35.15
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- PPL 44.93
- BNTX 48.71
- Support Level
- PPL $31.52
- BNTX $109.52
- Resistance Level
- PPL $32.78
- BNTX $115.34
- Average True Range (ATR)
- PPL 0.50
- BNTX 4.24
- MACD
- PPL -0.06
- BNTX -0.72
- Stochastic Oscillator
- PPL 40.65
- BNTX 27.24
About PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. LG&E and KU are involved in regulated electricity generation, transmission, and distribution in Kentucky. The Kentucky utilities also serve gas customers. Rhode Island Energy operates electric and gas utilities in Rhode Island.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.